Vibrocil oral drops, 15 mL per bottle
Ingredients
Active ingredients: dimetindene maleate, phenylephrine;
1 mL of the product contains 0.25 mg of dimethindene maleate and 2.5 mg of phenylephrine;
Excipients: sorbitol (E 420), anhydrous sodium hydrophosphate, citric acid monohydrate, lavender oil, benzalkonium chloride, purified water.
Dosage Form
Nasal drops.
Main physical and chemical properties: a clear solution, no more intensely colored than Yellow No. 3.
Pharmacotherapeutic group
Decongestants and other rhinological preparations for topical use. Sympathomimetics, combinations, excluding corticosteroids.
ATC code R01 AB.
Pharmacological properties
Vibrocil is a combination drug containing phenylephrine and dimetindene.
Pharmacodynamics.
The drug reduces nasal discharge and helps clear the nasal passages without disrupting the physiological functions of the ciliated epithelium and the nasal mucosa.
Phenylephrine belongs to the class of sympathomimetic amines. It is used as a nasal decongestant with moderate vasoconstrictive action, selectively stimulating alpha-1-adrenergic receptors in the cavernous venous tissue of the nasal mucosa. Thus, it rapidly and persistently relieves swelling of the nasal mucosa and its paranasal sinuses.
Dimethindene—an H1-histamine receptor antagonist—exerts an antiallergic effect. It is effective when used in low doses and is well tolerated.
Pharmacokinetics.
Vibrocil is administered topically; therefore, its activity does not correlate with the concentration of active ingredients in blood plasma.
In cases of accidental oral ingestion, the bioavailability of phenylephrine was reduced to approximately 38% due to first-pass metabolism in the intestines and liver; the half-life is approximately 2.5 hours.
The systemic bioavailability of dimetindene after oral administration in solution is approximately 70%, with a half-life of about 6 hours.
Indications
In adults and children aged 2 years and older:
- symptomatic treatment of the common cold, nasal congestion, acute and chronic rhinitis, seasonal (hay fever) and non-seasonal allergic rhinitis, acute and chronic sinusitis, and vasomotor rhinitis. Adjuvant therapy for acute otitis media.
Preparation for surgical procedures in the nasal area, and reduction of swelling of the nasal mucosa and paranasal sinuses following surgery.
Contraindications
Hypersensitivity to phenylephrine, dimetindene maleate, or any of the excipients.
Due to its phenylephrine content, this medication, like other vasoconstrictors, is contraindicated in cases of atrophic rhinitis, angle-closure glaucoma, as well as in patients taking monoamine oxidase (MAO) inhibitors or who have taken them within the previous 14 days.
Drug Interactions and Other Interactions
Concomitant use of this medication with monoamine oxidase (MAO) inhibitors and within 14 days after their use is contraindicated.
Vasoconstrictors should be prescribed with caution in combination with tricyclic and tetracyclic antidepressants and antihypertensive drugs, such as β-blockers, as their concurrent use may potentiate the pressor effect of phenylephrine.
Special Considerations for Use
Vibrocil, like other sympathomimetics, should be used with caution in patients with a pronounced reaction to adrenergic agents, manifested by symptoms such as insomnia, dizziness, tremor, cardiac arrhythmias, or increased blood pressure.
Vibrocil should not be used continuously for more than 3 days. If symptoms persist for more than 3 days or worsen, consult a doctor. Prolonged or excessive use of the drug may cause tachyphylaxis and a rebound effect (medication-induced rhinitis).
As with other vasoconstrictors, do not exceed the recommended dose. Excessive use of the medication, especially in children and the elderly, may lead to systemic effects.
This medication should be prescribed with caution to patients with cardiovascular disease, hypertension, hyperthyroidism, diabetes mellitus, and patients with bladder neck obstruction (e.g., benign prostatic hyperplasia).
Due to its content of the H1-antihistamine dimetindene maleate, Vibrocil should be used with caution in patients with epilepsy.
Use during pregnancy or breastfeeding.
No studies have been conducted on the use of phenylephrine and dimetindene maleate during pregnancy or breastfeeding. Given the potential systemic vasoconstrictive effect of phenylephrine, it is recommended to refrain from using this medication during pregnancy.
It is recommended to avoid using this medication while breastfeeding.
Fertility
There are no adequate data on the effects of phenylephrine and dimetindene maleate on human fertility.
Ability to affect reaction time when driving or operating machinery.
No data available.
Dosage and Administration
Thoroughly clean the nose before administering the medication. The patient should tilt their head back while sitting or standing, or to the side if lying in bed. After instilling the drops, it is recommended to keep the head tilted back for a few minutes to allow the medication to spread throughout the nasal cavity.
Wash and dry the dropper cap before screwing it onto the bottle.
Children aged 2 to 6 years
1–2 drops in each nostril 3–4 times a day.
Children 6 years of age and older and adults
3–4 drops in each nostril 3–4 times a day.
The duration of continuous treatment should not exceed 3 days and depends on the course of the illness. Use of the product in children aged 2 to 12 years should be supervised by an adult.
Children.
Vibrocil nasal drops are not recommended for use in children under 2 years of age.
Overdose
In case of overdose, Vibrocil may cause the following sympathomimetic and anticholinergic effects: increased heart rate, premature ventricular contractions, pain in the back of the head, shaking or tremor, mild tachycardia, elevated blood pressure, mydriasis, numbness, agitation, hallucinations, convulsions, insomnia, and pallor. Overdose with this medication may cause mild sedation, increased fatigue, coma, stomach pain, nausea, and vomiting.
No serious side effects have been reported following accidental administration of Vibrocil. Accidental ingestion of doses of dimetindene up to 20 mg has not resulted in severe symptoms.
Treatment: administer activated charcoal and, if necessary, laxatives to young children (gastric lavage is not required); adults and older children should be given plenty of fluids to drink.
Phenylephrine-induced hypertension that does not respond adequately to benzodiazepines can be treated with an alpha-adrenergic blocker. Central anticholinergic symptoms can be treated with physostigmine. It is advisable to consult a physician regarding the use of antidotes. Since there are no data on the absorption of dimethindene doses exceeding 20 mg in the gastrointestinal tract, patients with a significant overdose should be monitored by a physician and, if prescribed by a doctor, given a single dose of activated charcoal. Severe cases of agitation and seizures should be treated with benzodiazepines.
Side Effects
The drug is generally well tolerated. The adverse reactions listed below are categorized by frequency as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), frequency unknown (cannot be estimated from the available data).
Respiratory, thoracic, and mediastinal disorders: rarely—nasal discomfort, nasal dryness, nosebleeds.
General disorders and administration site conditions: rare—burning sensation at the application site; very rare—general weakness, development of allergic reactions (including local skin reactions, itching of the body, swelling of the eyelids and face).
Shelf life
3 years.
Storage conditions
Store in the original packaging, protected from light and heat, at a temperature not exceeding 25 °C. Keep out of reach of children.
Packaging
15 mL of drops in a bottle with a dropper cap; 1 bottle per cardboard box.
Dispensing Category
Available without a prescription.
Manufacturer
GSK Consumer Healthcare S.A.R.L.
Manufacturer’s location and business address.
Route de l’Etraz, Nyon, 1260, Switzerland.
Similar products
Products from the same category









